Fixed-Dose Combinations Pragmatic Randomized Implementation Trial for Blood Pressure Control
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT07228065
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Hypertension
- Primary Care
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Provider nudge — BEHAVIORALPharmacists will deliver targeted nudges to providers through clinical decision support integrated into the electronic health record (EHR)
- Patient nudge — BEHAVIORALPatients will receive pharmacist-delivered nudges (e.g., text messages) 1-7 days before their visit to encourage fixed-dosed combinations
- Pharmacist Virtual Visit — BEHAVIORALPatients will receive pharmacist counseling and prescribing delivered via virtual encounters after their visit
Study Details
The proposed study is an effectiveness-implementation hybrid type II trial designed to evaluate the impact of provider- and patient-directed interventions on FDC use. The trial will test the effectiveness of theory-driven nudges tailored to address provider and patient barriers. All interventions will be pharmacist-driven, with pharmacists delivering information via nudges to providers and via nudges or more intensive interventions (i.e., CPA) to patients. Data to evaluate outcomes will be extracted from electronic health records.
Key Dates
- First listed
- Nov 13, 2025
- Start date
- Jul 31, 2026
- Status verified
- Jun 2026
- Primary completion
- Apr 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 720 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Active Comparator: Provider nudge onlyPharmacists will deliver targeted nudges to providers through clinical decision support integrated into the EHR.
- Experimental: Provider nudge + Patient nudgeIn addition to provider nudges (Provider nudge only arm), patients will receive pharmacist delivered nudges (e.g., text messages) 1-7 days before the visit to encourage fixed dose combination medications.
- Experimental: Provider nudge + Pharmacist Virtual VisitIn addition to provider nudges (Provider nudge only arm), patients will receive pharmacist counseling and prescribing delivered via virtual encounters after the visit.
Primary Outcome Measure
Change in systolic blood pressure [ Time Frame: 6 months ]
Central Contacts
- Julie Lauffenburger, PharmD, PhD617-525-8865
- Rasha Khatib, PhD, MHS
Find similar trials
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Effect of Electro-Acupuncture on Blood PressureRecruiting · University of California, Irvine · Irvine, California
- Metabolic Effects of Angiotensin-(1-7)PHASE1 · Recruiting · Vanderbilt University · Nashville, Tennessee
- : Vascular Function in Health and DiseasePHASE1 · Recruiting · Russell Richardson · Salt Lake City, Utah